Stockreport

Regenxbio: Cautiously Bullish After FDA Setbacks [Seeking Alpha]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF RGX-314 is being developed in partnership with AbbVie, targeting wet AMD and diabetic retinopathy. These are sizeable TAMs, which could pay off in the long run. RGX-2 [Read more]